FOXM1 and gastric cancer: In addition, Li et al. [34] found, for the first time, that TSA had the role of enhancing the sensitivity of GC cells to TRAIL through the ERK/FOXM1 pathway, revealing that FOXM1 may be used as a biomarker to predict the sensitivity of GC cells to TRAIL.